CIQ, the support and services partner of Rocky Linux and provider of high-performance software infrastructure, today - Read ...
A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...
Threat actors are systematically hunting for misconfigured proxy servers that could provide access to commercial large ...
In the third part of her conversation with PharmExec, Trialynx founder and CEO Angela Schwab discusses the causes and ...
"MetaVia OXM analogue agonist meets endpoints in Phase Ib weight loss trial" was originally created and published by Clinical ...
PE: How is AI supporting clinical trial design? Schwab: We have a hit a new era of clinical trial design. Up until 2024, ...
Security teams have always known that insecure direct object references (IDORs) and broken authorization vulnerabilities exist in their codebases. Ask any ...
By Exec Edge Editorial Staff Behind every scientific breakthrough at Colossal Biosciences stands a question that transcends ...
This is the year when long-ignored cybersecurity risks stop being theoretical and start demanding action, says Juusola ...
Blue collar autonomy is an unadvertised hero of the AoT™ revolution. Critical infrastructure monitoring is an area that is ...
Artificial Analysis overhauls its AI Intelligence Index, replacing saturated benchmarks with real-world tests measuring ...
Company now expects to complete enrollment of 150 patients in Q2 2026, with a Phase 3 data readout in mid-2027; Rolling NDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback